Neal Benowitz, MD
Professor
Medicine
School of Medicine

415-502-1034

Neal Benowitz has been involved in patient care and conducting research at SFGH since 1973. His research focus is on the human pharmacology of nicotine in relation to pathogenesis of and individual differences in vulnerability to tobacco-related disease, and the use of pharmacologic data as a basis for public health policies to prevent and reduce such disease.

Show full bio (100 words) Hide full bio

He has also studied the human pharmacolgy and toxicology of cannabis products. He has served on a number of national and international committees addressing issues in tobacco-related diseases and smoking cessation, including several sponsored by the Institute of Medicine. He has served as president of the American Society for Clinical Pharmacology and Therapeutics and the Society for Research on Nicotine and Tobacco. He has authored over 700 publications, including a state-of-the-art review on nicotine addiction in the New England Journal of Medicine in June 2010. He maintains an active clinical practice in cardiology and medical toxicology

Education & Training

Show all (1) Hide

  • Residency School of Medicine - Internal Medicine University of California, San Francisco

Websites

Show all (1) Hide

Grants and Projects

Show all (16) Hide

Publications (806)

Top publication keywords:
Cigarette SmokingBupropionCotinineNicotinic AgonistsElectronic Nicotine Delivery SystemsAryl Hydrocarbon HydroxylasesCarcinogensTobacco ProductsNicotineSmokingTobacco Use DisorderTobacco Smoke PollutionNitrosaminesSmoking CessationVaping

Show all (801 more) Hide